AstraZeneca Cuts 600 Sales Jobs in US, Bloomberg News Reports
6 days ago
AstraZeneca cut approximately 600 US sales jobs in respiratory and immunology teams as part of a $1.5 billion annual cost-saving initiative. The move supports the company's goal of reaching $80 billion in annual revenue by 2030.